Hengrui Pharma and Bristol Myers Squibb announced the companies have entered into global strategic collaboration and license agreements to advance a portfolio of 13 early stage programs in oncology, hematology and immunology, with the goal of accelerating discovery and development of innovative medicines for the benef…
GI Partners, a leading private investment firm, announced it has completed the acquisition of the Contract Development and Manufacturing Organization (CDMO) and Cell Solutions businesses from Charles River Laboratories International, Inc., forming Rose BioSolutions ("Rose Bio"), a leading provider of advanced manufact…
Made Scientific, Inc., a U.S.-based clinical and commercial cell therapy contract development and manufacturing organization (CDMO), and RoosterBio, Inc., a leading supplier of human mesenchymal stem cells (MSCs), engineered bioprocess media, and bioprocess development services, announced a strategic partnership integ…
Alcami Corporation, a leading U.S.-based contract development and manufacturing organization (CDMO), announced the completion of the acquisition of Tjoapack, a leading global contract packaging organization with facilities in the United States and The Netherlands. The combined organization now employs over 1,400 skil…
Lunai Bioworks, has completed a $20 million preferred equity issuance to acquire intellectual property assets from two counterparties, strengthening its central nervous system (CNS) platform with new neurotherapeutic compounds and delivery technologies. The acquisition is designed to address a key challenge in neurolo…
Huahui Health announced that it has entered into a global exclusive option, license and collaboration agreement with BeOne Medicines for HH160, a novel trispecific antibody in oncology immunotherapy. Under the agreement, BeOne Medicines is granted an exclusive option covering the development, manufacturing, and commer…
PerZeption is set to present new data validating its AIM+ CSF modeling technology at the Association of Research in Vision and Ophthalmology (ARVO) annual meeting. "We are very excited to collaborate with Alcon, one of the largest companies within the Ophthalmology sector worldwide. ", Dr. Jan Skerswetat said. "The r…
CellProthera announces a new collaboration to optimize manufacturing processes using Quintessence’s technology, preparing its cell therapy to advance into clinical trials for the treatment of ischemic stroke. Quintessence Biotech, a developer of cell processing technologies, has completed proof-of-concept testing for …
Azra AI, the leading end-to-end enterprise platform for incidental findings and oncology workflow automation, announced the acquisition of Thynk Health, the specialized leader of lung cancer screening and incidental findings management. The deal unites two of healthcare's most trusted names in imaging-driven care coor…
Eli Lilly and Company and Ajax Therapeutics, Inc. , a biopharmaceutical company developing next generation JAK inhibitors for patients with myeloproliferative neoplasms (MPNs), announced a definitive agreement for Lilly to acquire Ajax. Ajax's lead asset, AJ1-11095, is an investigational, once-daily oral, first-in-cla…
Page 16 of 43